Study ID: CTSU S1201
Description:

Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1 (Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric, or Gastroesophageal Junction (GEJ) Cancer

Location:
Sioux Falls Region,Fargo Region,Bemidji Clinic
Principal Investigator:
Miroslaw Mazurczak MD,Preston Steen MD
Disease:
Esophagus, GE Junction, Stomach
Stage:
Phase II

Status:

Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.

Back to Clinical Trials list